15x Better Than Niacinamide? 30% Better Than Vitamin C? Meet Debut’s DermCeuticalPRO Ingredients

by админ

Debut’s DermCeuticalPRO Collection introduces novel, bio-based ingredients with transformative effects, backed by science and clinical testing.Wasabi at Adobe Stock

15x Better Than Niacinamide? 30% Better Than Vitamin C? Meet Debut's DermCeuticalPRO Ingredients

Debut utilizes advanced genomics-based AI to discover groundbreaking ingredients, merging cutting-edge technology with beauty.DebutJoin us for an exclusive webinar, Biotech’s New Beauty Heroes, which will introduce Debut’s DermCeuticalPRO Collection–a new era of biotech-powered beauty ingredients. Discover scientifically proven, 100% bio-based ingredients that deliver transformative results, enhanced potency and unmatched sustainability.

Key topics include: 

✨ How biotech is revolutionizing beauty with AI-powered ingredient discovery 

✨ The science behind DermCeuticalPRO’s clinical claims and performance 

✨ The growing fusion of beauty, biotech and pharma 

The DermCeuticalPRO range currently comprises a trio of ingredient technologies, including:

  • InflammagePRO, an inflammaging technology that is 15x better than niacinamide at reducing markers of inflammation, per Debut
  •  Barrier RepairPRO, which is 30% better than vitamin C for skin damage repair, according to the company
  • LongevityPRO, which is reportedly 2x better than vitamin C for cellular longevity

Be among the first to explore these game-changing innovations. Plus, the first 100 registrants get 10% off their first contract manufacturing order with Debut’s BiotechXBeautyLabs. 

  • Date: Wednesday, March 26, 2025
  • Time: 10:00 AM Eastern

Sign up now to lead the future of beauty!

Meet the Experts

  • Joshua Britton, PhD: Founder and CEO of Debut, pioneering sustainable biotechnology for the beauty industry. Leads a 100+ member team, holds 70+ patents, and has raised $70M in funding from top investors like L’Oréal’s BOLD. Holds advanced degrees from MIT, UC Irvine, and Nottingham University.
  • Taylor Oswald: Director of Ingredient & Product Innovation at Debut with 10+ years of life science experience. Specializes in AI development, novel ingredient discovery, and formulation of high-performing beauty products. Holds a MS in Medical Microbiology from the University of Florida and a BS from Gonzaga University.
See also
The Estée Lauder Companies' Fabrizio Freda Sets Retirement Amid Fiscal 2024 Hit by China 'Softness'

5 Key Takeaways for Marketers, Product Developers, R&D Leaders and More…

  1. Biotech Unlocks Next-Gen Ingredients: Debut’s DermCeuticalPRO Collection introduces novel, bio-based ingredients with transformative effects, backed by science and clinical testing.
  2. Enhanced Performance with Sustainability: Precision biotech creates potent, targeted ingredients at lower concentrations, reducing skin sensitization while eliminating reliance on petroleum and cultivated resources.
  3. AI-Powered Innovation: Debut utilizes advanced genomics-based AI to discover groundbreaking ingredients, merging cutting-edge technology with beauty.
  4. Convergence of Biotech and Pharma: The growing overlap between biotech and pharmaceuticals is shaping the future of beauty, delivering science-backed solutions with measurable results.
  5. Custom Formulation Opportunities: Through BiotechXBeautyLabs, brands can access tailored formulations and contract manufacturing services, with early registrants receiving exclusive discounts.

    Sign up now to lead the future of beauty!

    Related Posts

    U